<DOC>
	<DOCNO>NCT00490555</DOCNO>
	<brief_summary>The investigator propose examine vivo response hormonal manipulation molecular level directly tissue interest ( prostate ) . As investigator ' previous , pilot study , investigator use novel approach procure tissue specimen normal , healthy men might choose use male hormonal contraceptive regimen available . The investigator employ state art technique laser capture microdissection ( LCM ) cDNA microarrays determine tissue-specific consequence male hormonal contraceptive regimen prostate . The result help guide design , safety monitoring , selection male hormonal contraceptive agent provide valuable insight prostate human prostate biology . The investigator test hypothesis exogenous T administration result increase circulate T dihydrotestosterone ( DHT ) level increase intraprostatic concentration T metabolite DHT . The investigator test hypothesis addition potent 5α-reductase inhibitor , dutasteride , progestin , Depomedoxyprogesterone ( IM DMPA ) , T administration young middle age men decrease intraprostatic DHT increase intraprostatic T concentration compare T alone . The investigator test hypothesis addition 5α-reductase inhibitor dutasteride progestin IM DMPA exogenous T , reduce intraprostatic DHT , decrease prostate epithelial proliferation , assess Ki-67 label index ( Ki-67LI ) , increase apoptosis , assess caspase-3 expression , decrease androgen-regulated protein expression prostate specific antigen ( PSA ) . The investigator test hypothesis addition 5α-reductase inhibitor progestin IM DMPA exogenous T , modify intraprostatic hormonal milieu , alter prostate epithelial gene expression . Specifically , investigator expect addition 5α-reductase inhibitor dutasteride progestin IM DMPA exogenous T , result decreased expression androgen-regulated gene PSA .</brief_summary>
	<brief_title>PROS-1-Male Hormonal Contraceptive Regimens Prostate Tissue</brief_title>
	<detailed_description>The purpose research study understand effect testosterone prostate . This knowledge use help development safe male hormonal contraception . We administer three drug study : Testim ( testosterone ( T ) gel ) , dutasteride ( affect testosterone break ) Depomedoxyprogesterone ( DMPA , progestin ) . We want see effect level hormone blood prostate . In addition , examine effect drug expression gene within prostate . DMPA suppress LH FSH , hormone make pituitary gland , thus block signal brain cause testis make testosterone . Prolonged ( &gt; 1 month ) low level LH FSH cause decrease sperm production normal men . However , men may experience side effect low level testosterone cause DMPA ; add testosterone DMPA eliminate side effect effectively block LH FSH release sperm production . This combination drug promise male contraceptive regimen . However , effect drug prostate know . Some study suggest testosterone administration may promote prostate growth . Dutasteride block conversion testosterone dihydrotestosterone use treat men enlarge prostate . Dutasteride shrinks prostate . It possible combine testosterone dutasteride may effective part male hormonal contraceptive regime . Therefore , study examine effect testosterone , DMPA dutasteride prostate need .</detailed_description>
	<mesh_term>Dutasteride</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<criteria>Men good health , without history chronic androgen therapy know history gonadal prostate abnormality . PSA ≤ 2 . Age 2555 year Ability understand study , study procedure provide consent Normal serum total T , LH , FSH , urine analysis , sperm count &gt; equal 15million/ml International Prostate Symptom Score ( IPSS ) &lt; 10 Normal seminal fluid analysis ( &gt; 20 million sperm/ml ) Agree donate blood treatment recovery period A history evidence prostate breast cancer History invasive therapy BPH History acute urinary retention Current past treatment 5αreductase inhibitor History anti/androgenic drug drug interfere steroid metabolism within past 3 month Severe systemic illness ( renal , liver , cardiac , lung disease , cancer , poorly control diabetes ) Known untreated obstructive sleep apnea Hematocrit &gt; 52 % Skin disease might interfere T gel absorption Hypersensitivity drug use study History bleed disorder anticoagulation History drug alcohol abuse within 12 month History infertility desire fertility within 12 month , current pregnant partner A firstdegree relative ( i.e . father , brother ) history prostate cancer Abnormal digital rectal examination prostate ultrasound</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Male Contraception</keyword>
	<keyword>Testosterone</keyword>
	<keyword>Testis</keyword>
	<keyword>Contraception</keyword>
	<keyword>Prostate</keyword>
</DOC>